VOYA Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.74M | Buy |
|
|||||
|
2025
Q1 | $1.55M | Sell |
|
|||||
|
2024
Q4 | $1.83M | Sell |
|
|||||
|
2024
Q3 | $3.9M | Buy |
|
|||||
|
2024
Q2 | $977K | Sell |
|
|||||
|
2024
Q1 | $2.68M | Sell |
|
|||||
|
2023
Q4 | $3.03M | Buy |
|
|||||
|
2023
Q3 | $2.22M | Buy |
|
|||||
|
2023
Q2 | $1.16M | Sell |
|
|||||
|
2023
Q1 | $1.78M | Sell |
|
|||||
|
2022
Q4 | $4.5M | Sell |
|
|||||
|
2022
Q3 | $4.25M | Buy |
|
|||||
|
2022
Q2 | $128K | Buy |
|
|||||
|
2022
Q1 | $222K | Buy |
|
|||||
|
2021
Q4 | $179K | Sell |
|
|||||
|
2021
Q3 | $254K | Buy |
|
|||||
|
2021
Q2 | $302K | Sell |
|
|||||
|
2021
Q1 | $265K | Buy |
|
|||||
|
2020
Q4 | $260K | Buy |
|
|||||
|
2020
Q3 | $150K | Hold |
|
|||||
|
2020
Q2 | $115K | Sell |
|
|||||
|
2020
Q1 | $133K | Hold |
|
|||||
|
2019
Q4 | $183K | Buy |
|
|||||
|
2019
Q3 | $140K | Hold |
|
|||||
|
2019
Q2 | $196K | Buy |
|
|||||
|
2019
Q1 | $176K | Hold |
|
|||||
|
2018
Q4 | $158K | Hold |
|
|||||
|
2018
Q3 | $220K | Hold |
|
|||||
|
2018
Q2 | $194K | Buy |
|
|||||
|
2018
Q1 | $228K | Hold |
|
|||||
|
2017
Q4 | $250K | Buy |
|
|||||
|
2017
Q3 | $136K | Hold |
|
|||||
|
2017
Q2 | $146K | Buy |
|
|||||
|
2017
Q1 | $136K | Hold |
|
|||||
|
2016
Q4 | $98K | Hold |
|
|||||
|
2016
Q3 | $151 | Hold |
|
|||||
|
2016
Q2 | $92K | Hold |
|
|||||
|
2016
Q1 | $86K | Hold |
|
|||||
|
2015
Q4 | $125K | Hold |
|
|||||
|
2015
Q3 | $102K | Sell |
|
|||||
|
2015
Q2 | $189K | Sell |
|
|||||
|
2015
Q1 | $242K | Sell |
|
|||||
|
2014
Q4 | $215K | Sell |
|
|||||
|
2014
Q3 | $183K | Hold |
|
|||||
|
2014
Q2 | $343K | Hold |
|
|||||
|
2014
Q1 | $367K | Hold |
|
|||||
|
2013
Q4 | $270K | Hold |
|
|||||
|
2013
Q3 | $339K | Hold |
|
|||||
|
2013
Q2 | $316K | Buy |
|